SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-128423
Filing Date
2008-06-05
Accepted
2008-06-05 08:00:07
Documents
2
Period of Report
2008-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18970
2 FORBEARANCE NO.2, LIMITED WAIVER AND MODIFICATION TO LOAN AND SECURITY AGREEMENT dex101.htm EX-10.1 35272
  Complete submission text file 0001193125-08-128423.txt   56001
Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062
Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001
BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15360 | Film No.: 08881948
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10